TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2024
Back to search
Official data from USPTO
DELLA TERRA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DELLA TERRA PHARMACEUTICALS
ST13
US500000090877382Class
42
Filing
90877382
Registration
6850209
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
02/01/2024
Trademark type
Word
Nice classes
42
Filing date
08/11/2021
Registration date
09/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2022
Last transaction
02/01/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-01-00
First use in commerce
2022-01-00
Drawing code
4
Owner type
16
Owner location
Marietta, GA
Examiner
HELMERS,SARA A
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PNW Holdings, LLC
Representatives
John VanOphem VanOphem IP Law PLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
botanical pharmaceutical and nutraceutical drug substance and drug product development services; research and development of pharmaceuticals and nutraceuticals
Publications
History of USPTO decisions and trademark events.
23 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2022
PUBO
PUBLISHED FOR OPPOSITION
07/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/15/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
06/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/31/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/31/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/31/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/31/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/31/2022
IUAA
USE AMENDMENT ACCEPTED
05/31/2022
DOCK
ASSIGNED TO EXAMINER
05/24/2022
DOCK
ASSIGNED TO EXAMINER
05/12/2022
DOCK
ASSIGNED TO EXAMINER
05/11/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/12/2022
IUAF
USE AMENDMENT FILED
04/12/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2021
NWAP
NEW APPLICATION ENTERED
08/14/2021
Continuous trademark protection
Get notified about every new filing that threatens DELLA TERRA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.